Search

Compugen Ltd

Uždarymo kaina

2.22 -1.33

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.21

Max

2.3

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-65M

-7.7M

Pardavimai

-65M

2.2M

P/E

Sektoriaus vid.

5.95

64.641

Pelnas, tenkantis vienai akcijai

-0.08

Pelno marža

-352.436

Darbuotojai

75

EBITDA

-64M

-7.7M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+121.24% upside

Dividendai

By Acuity

Kitas uždarbis

2026-08-03

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-45M

225M

Ankstesnė atidarymo kaina

3.55

Ankstesnė uždarymo kaina

2.22

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-28 23:56; UTC

Correlated Moves

Shares of T Rowe Price Group Inc declined in after-market trading, reversing a trend of higher closes over the previous three sessions.

2026-07-28 23:56; UTC

Krispy Kreme Inc shares are higher in after-market hours, reflecting broader market gains driven by strong earnings from Coca-Cola and UPS.

2026-07-28 23:56; UTC

Northern Trust Corp shares are trading lower in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

2026-07-28 23:56; UTC

Yelp Inc shares are higher in after-market hours, continuing a recent upward trend amid broader market gains driven by strong earnings from Coca-Cola and UPS.

2026-07-28 23:56; UTC

Correlated Moves

ProPetro Holding Corp shares rose during after-market hours, aligning with a 3.61% increase in the VanEck Oil Services ETF amid positive sector sentiment.

2026-07-28 23:56; UTC

Correlated Moves

Encore Capital Group shares rose in after-market hours, reflecting positive market sentiment. The Russell 2000 Index also increased, supporting investor confidence.

2026-07-28 23:56; UTC

Immunovant Inc shares higher in after-market trading, reflecting broader market strength amid positive earnings from companies like UPS and Coca-Cola.

2026-07-28 23:56; UTC

Palo Alto Networks shares rose in after-market trading, supported by broader market gains and strong earnings from companies like Coca-Cola and UPS.

2026-07-28 23:56; UTC

Carvana Co shares are lower in after-market trading, with no specific news identified to explain the decline. The stock reversed from earlier gains.

2026-07-28 23:56; UTC

Rollins Inc. shares rose slightly in after-market trading, with no specific news identified. Broader market gains were supported by strong earnings from UPS and Coca-Cola.

2026-07-28 23:56; UTC

Viasat Inc. shares rose in after-market trading, reflecting broader market strength from positive earnings reports, including those from Coca-Cola and UPS.

2026-07-28 23:56; UTC

News

Coursera Inc announced a $100 million investment in LearnVector, enhancing its AI strategy. Shares are trading higher during after-market hours.

2026-07-28 23:56; UTC

Correlated Moves

Pentair PLC's shares were roughly flat in after-market hours amid broader market gains driven by strong earnings from Coca-Cola and UPS.

2026-07-28 23:56; UTC

Iovance Biotherapeutics shares declined in after-market trading, continuing a trend of lower finishes over the past five sessions. No specific news was identified.

2026-07-28 23:56; UTC

Microchip Technology Inc shares are lower in after-market trading, continuing a six-session decline amid a broader market rally driven by strong earnings from UPS.

2026-07-28 23:56; UTC

Correlated Moves

Vishay Intertechnology shares are lower in after-hours trading, continuing a decline seen since Tuesday. The stock remains below its 20-day moving average.

2026-07-28 23:56; UTC

Viavi Solutions Inc shares are lower in after-market trading. No specific news was identified to explain the decline amid broader market gains.

2026-07-28 23:56; UTC

Arista Networks Inc shares are lower in after-market hours. No specific news was identified for the decline, which follows three consecutive sessions of losses.

2026-07-28 23:56; UTC

Geo Group Inc shares are higher in after-market hours, supported by broader market strength from strong earnings reports, including those from UPS and Coca-Cola.

2026-07-28 23:56; UTC

Borgwarner Inc shares are higher in after-market trading, rebounding from an earlier dip amid broader market gains driven by strong earnings from UPS and Coca-Cola.

2026-07-28 23:52; UTC

News
Correlated Moves
Social Media

Apple Inc. shares are higher in after-market trading as the company surpasses a $5 trillion market capitalization ahead of its Q3 earnings report.

2026-07-28 23:52; UTC

OUTFRONT Media Inc shares are lower in after-market trading, declining since Tuesday's close despite three consecutive sessions of gains. No specific news was identified.

2026-07-28 23:52; UTC

Mexican Consumer Confidence Index Set for Release Amid Global Mixed Signals and Local Pessimism, Anticipated to Reflect Economic Sentiment on August 4, 2026.

2026-07-28 23:52; UTC

Brazil's Industrial Production MoM data for June 2026 set to release on August 4, amid cautious market sentiment following May's unexpected decline.

2026-07-28 23:52; UTC

Brazil's Central Bank Faces Mixed Market Sentiment Ahead of August 2026 Interest Rate Decision Amid Inflation and Economic Concerns.

2026-07-28 23:52; UTC

Australia's Producer Price Inflation (PPI) set for July 31, with a projected 0.3% increase amid cautious inflation sentiment and potential interest rate hikes from the Reserve Bank of Australia.

2026-07-28 23:52; UTC

South Korea's S&P Global Manufacturing PMI set for August 3, with expectations of declining activity amid rising costs and significant stock market drops.

2026-07-28 23:52; UTC

China's Non-Manufacturing PMI set for July 31 release, forecasted at neutral 50.0 amid mixed economic sentiment and geopolitical tensions.

2026-07-28 23:52; UTC

China's NBS Manufacturing PMI forecasted to hold steady at 50.0, signaling stagnation amid mixed global manufacturing signals ahead of July 31st release.

2026-07-28 23:52; UTC

Social Media
News

Avis Budget Group shares lower in after-market trading following second-quarter results that missed expectations, with EPS of $0.98 against estimates of $1.91.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

121.24% į viršų

12 mėnesių prognozė

Vidutinis 5 USD  121.24%

Aukščiausias 6 USD

Žemiausias 4 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat